Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition

被引:64
作者
Keserue, Benjamin [1 ]
Barbosa-Sicard, Eduardo [1 ]
Schermuly, Ralph T. [2 ,3 ]
Tanaka, Hiromasa [4 ]
Hammock, Bruce D. [4 ]
Weissmann, Norbert [2 ]
Fisslthaler, Beate [1 ]
Fleming, Ingrid [1 ]
机构
[1] Goethe Univ Frankfurt, Inst Vasc Signalling, D-60590 Frankfurt, Germany
[2] Univ Giessen, Dept Internal Med 2 5, Lung Ctr, Giessen, Germany
[3] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany
[4] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA
关键词
Cytochrome P450; Epoxyeicosatrienoic acid; Hypoxia; Pulmonary hypertension; Soluble epoxide hydrolase; EPOXYEICOSATRIENOIC ACIDS; EXPRESSION; VASOCONSTRICTION; PHOSPHATASE; STROKE; POLYMORPHISMS; PRESSURE; REVEALS; RISK; MICE;
D O I
10.1093/cvr/cvp281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The C-terminal domain of the soluble epoxide hydrolase (sEH) metabolizes epoxyeicosatrienoic acids (EETs) to their less active diols, while the N-terminal domain demonstrates lipid phosphatase activity. As EETs are potent vasoconstrictors in the pulmonary circulation, we assessed the development of pulmonary hypertension induced by exposure to hypoxia (10% O-2) for 21 days in wild-type (WT) and sEH(-/-) mice and compared the effects with chronic (4 months) sEH inhibition. Methods and results In isolated lungs from WT mice, acute hypoxic vasoconstriction (HPV) was potentiated by sEH inhibition and attenuated by an EET antagonist. After prolonged hypoxia, the acute HPV and sensitivity to the EET antagonist were increased, but potentiation of vasoconstriction following sEH inhibition was not evident. Chronic hypoxia also stimulated the muscularization of pulmonary arteries and decreased sEH expression in WT mice. In normoxic sEH(-/-) mice, acute HPV and small artery muscularization were greater than that in WT lungs and enhanced muscularization was accompanied with decreased voluntary exercise capacity. Acute HPV in sEH(-/-) mice was insensitive to sEH inhibition but inhibited by the EET antagonist and chronic hypoxia induced an exaggerated pulmonary vascular remodelling. In WT mice, chronic sEH inhibition increased serum EET levels but failed to affect acute HPV, right ventricle weight, pulmonary artery muscularization, or voluntary running distance. In human donor lungs, the sEH was expressed in the wall of pulmonary arteries, however, sEH expression was absent in samples from patients with pulmonary hypertension. Conclusion These data suggest that a decrease in sEH expression is intimately linked to pathophysiology of hypoxia-induced pulmonary remodelling and hypertension. However, as sEH inhibitors do not promote the development of pulmonary hypertension it seems likely that the N-terminal lipid phosphatase may play a role in the development of this disease.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 38 条
[1]   Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo [J].
Ai, Ding ;
Fu, Yi ;
Guo, Deliang ;
Tanaka, Hiromasa ;
Wang, Nanping ;
Tang, Chaoshu ;
Hammock, Bruce D. ;
Shyy, John Y. -J. ;
Zhu, Yi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (21) :9018-9023
[2]   CDNA CLONING AND EXPRESSION OF A SOLUBLE EPOXIDE HYDROLASE FROM HUMAN LIVER [J].
BEETHAM, JK ;
TIAN, TG ;
HAMMOCK, BD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (01) :197-201
[3]   The soluble epoxide hydrolase as a pharmaceutical target for hypertension [J].
Chiamvimonvat, Nipavan ;
Ho, Chin-Min ;
Tsai, Hsing-Ju ;
Hammock, Bruce D. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (03) :225-237
[4]   Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat [J].
Corenblum, Mandi J. ;
Wise, Vance E. ;
Georgi, Katrin ;
Hammock, Bruce D. ;
Doris, Peter A. ;
Fornage, Myriam .
HYPERTENSION, 2008, 51 (02) :567-573
[5]   The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase [J].
Cronin, A ;
Mowbray, S ;
Dürk, H ;
Homburg, S ;
Fleming, I ;
Fisslthaler, B ;
Oesch, F ;
Arand, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1552-1557
[6]   An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats [J].
Dorrance, AM ;
Rupp, N ;
Pollock, DM ;
Newman, JW ;
Hammock, BD ;
Imig, JD .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (06) :842-848
[7]  
Durmowicz A G, 1999, Pediatr Rev, V20, pe91
[8]   Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis [J].
Enayetallah, AE ;
Grant, DF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (01) :254-260
[9]   Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide Hydrolase [J].
EnayetAllah, Ahmed E. ;
Luria, Ayala ;
Luo, Beibei ;
Tsai, Hsing-Ju ;
Sura, Priyanka ;
Hammock, Bruce D. ;
Grant, David F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (52) :36592-36598
[10]   Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans [J].
Gschwendtner, Andreas ;
Ripke, Stephan ;
Freilinger, Tobias ;
Lichtner, Peter ;
Mueller-Myhsok, Bertram ;
Wichmann, H. -Erich ;
Meitinger, Thomas ;
Dichgans, Martin .
STROKE, 2008, 39 (05) :1593-1596